skip to Main Content

Bacteria in Pancreatic Tumors Impact Immune Response and Survival, Study Examines Potential for Modulation

Bacteria in Pancreatic Tumors Impact Immune Response and Survival, Study Examines Potential for Modulation
A recent analysis, led by investigators at The University of Texas MD Anderson Cancer Center, demonstrated that long-term survivors of pancreatic cancer have different microbiome signatures in their tumor microenvironments that impact the immune system compared with patients categorized as short-term survivors. Research showed that the bacteria can either stimulate or suppress immune response in patients with pancreatic cancer.

When the investigators conducted a mouse model study of fecal microbiota transplants (FMT) from patients, they found that the mice with FMT from long-term survivors had smaller tumors compared with the short-term survivors or control donors due to the composition of the tumor microbiome.  Read more . . . 


Back To Top